It’s not merely a ‘shell’ company; it possesses a clearly defined business purpose. If successful in assuming control (acknowledging the inherent risk of failure), I aim to alter that business purpose. Why undertake the considerable effort of revitalizing an expert market OTC issuer, particularly one previously hijacked by apparent bad actors? The answer is straightforward: I relish challenges. I possess familiarity with the process, and my family office already retains a team of lawyers, bookkeepers, etc., on a monthly payroll, ensuring a plethora of tasks can be delegated. Additionally, I eschew overnight get-rich-quick schemes, favoring the establishment of sustainable business models. While these models may occasionally falter and necessitate adjustment, what intrigues me personally about endeavors like this is, and this is the crux of my pitch to existing shareholders, the fact that, to the best of my knowledge, NWGC is a dormant public issuer. If I secure court approval to endeavor to revitalize the issuer, whether through creation, development, or acquisition of a new business, what are the downsides compared to the current state of the company? Again, it’s crucial to emphasize that I still require court approval to proceed, and there exist numerous risks of failure. Nonetheless, I am committed to making the attempt.
